Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.
2.

A highly infectious Plasmodium yoelii parasite, bearing Plasmodium falciparum circumsporozoite protein.

Zhang M, Kaneko I, Tsao T, Mitchell R, Nardin EH, Iwanaga S, Yuda M, Tsuji M.

Malar J. 2016 Apr 12;15:201. doi: 10.1186/s12936-016-1248-z.

3.

Human immune system mice immunized with Plasmodium falciparum circumsporozoite protein induce protective human humoral immunity against malaria.

Huang J, Li X, Coelho-dos-Reis JG, Zhang M, Mitchell R, Nogueira RT, Tsao T, Noe AR, Ayala R, Sahi V, Gutierrez GM, Nussenzweig V, Wilson JM, Nardin EH, Nussenzweig RS, Tsuji M.

J Immunol Methods. 2015 Dec;427:42-50. doi: 10.1016/j.jim.2015.09.005. Epub 2015 Sep 26.

PMID:
26410104
4.

Imaging murine NALT following intranasal immunization with flagellin-modified circumsporozoite protein malaria vaccines.

Nacer A, Carapau D, Mitchell R, Meltzer A, Shaw A, Frevert U, Nardin EH.

Mucosal Immunol. 2014 Mar;7(2):304-14. doi: 10.1038/mi.2013.48. Epub 2013 Jul 3.

5.

Self-assembled peptide nanofibers raising durable antibody responses against a malaria epitope.

Rudra JS, Mishra S, Chong AS, Mitchell RA, Nardin EH, Nussenzweig V, Collier JH.

Biomaterials. 2012 Sep;33(27):6476-84. doi: 10.1016/j.biomaterials.2012.05.041. Epub 2012 Jun 12.

6.

Class II-restricted protective immunity induced by malaria sporozoites.

Oliveira GA, Kumar KA, Calvo-Calle JM, Othoro C, Altszuler D, Nussenzweig V, Nardin EH.

Infect Immun. 2008 Mar;76(3):1200-6. Epub 2007 Dec 26.

7.

A linear peptide containing minimal T- and B-cell epitopes of Plasmodium falciparum circumsporozoite protein elicits protection against transgenic sporozoite challenge.

Calvo-Calle JM, Oliveira GA, Watta CO, Soverow J, Parra-Lopez C, Nardin EH.

Infect Immun. 2006 Dec;74(12):6929-39. Epub 2006 Oct 9.

9.

Safety and enhanced immunogenicity of a hepatitis B core particle Plasmodium falciparum malaria vaccine formulated in adjuvant Montanide ISA 720 in a phase I trial.

Oliveira GA, Wetzel K, Calvo-Calle JM, Nussenzweig R, Schmidt A, Birkett A, Dubovsky F, Tierney E, Gleiter CH, Boehmer G, Luty AJ, Ramharter M, Thornton GB, Kremsner PG, Nardin EH.

Infect Immun. 2005 Jun;73(6):3587-97.

10.

Phase I testing of a malaria vaccine composed of hepatitis B virus core particles expressing Plasmodium falciparum circumsporozoite epitopes.

Nardin EH, Oliveira GA, Calvo-Calle JM, Wetzel K, Maier C, Birkett AJ, Sarpotdar P, Corado ML, Thornton GB, Schmidt A.

Infect Immun. 2004 Nov;72(11):6519-27.

11.

Immediate-type hypersensitivity and other clinical reactions in volunteers immunized with a synthetic multi-antigen peptide vaccine (PfCS-MAP1NYU) against Plasmodium falciparum sporozoites.

Edelman R, Wasserman SS, Kublin JG, Bodison SA, Nardin EH, Oliveira GA, Ansari S, Diggs CL, Kashala OL, Schmeckpeper BJ, Hamilton RG.

Vaccine. 2002 Dec 13;21(3-4):269-80. Erratum in: Vaccine. 2003 Jun 2;21(19-20):2689.

PMID:
12450702
12.

Delayed-type hypersensitivity in volunteers immunized with a synthetic multi-antigen peptide vaccine (PfCS-MAP1NYU) against Plasmodium falciparum sporozoites.

Kublin JG, Lowitt MH, Hamilton RG, Oliveira GA, Nardin EH, Nussenzweig RS, Schmeckpeper BJ, Diggs CL, Bodison SA, Edelman R.

Vaccine. 2002 Mar 15;20(13-14):1853-61.

PMID:
11906775
13.

A totally synthetic polyoxime malaria vaccine containing Plasmodium falciparum B cell and universal T cell epitopes elicits immune responses in volunteers of diverse HLA types.

Nardin EH, Calvo-Calle JM, Oliveira GA, Nussenzweig RS, Schneider M, Tiercy JM, Loutan L, Hochstrasser D, Rose K.

J Immunol. 2001 Jan 1;166(1):481-9.

14.

Synthetic malaria peptide vaccine elicits high levels of antibodies in vaccinees of defined HLA genotypes.

Nardin EH, Oliveira GA, Calvo-Calle JM, Castro ZR, Nussenzweig RS, Schmeckpeper B, Hall BF, Diggs C, Bodison S, Edelman R.

J Infect Dis. 2000 Nov;182(5):1486-96. Epub 2000 Oct 9.

PMID:
11023472
15.

Immunogenicity of chimeric multiple antigen peptides based on Plasmodium falciparum antigens: impact of epitope orientation.

Ahlborg N, Nardin EH, Perlmann P, Berzins K, Andersson R.

Vaccine. 1998 Jan;16(1):38-44.

PMID:
9607007
16.

Plasmodium falciparum polyoximes: highly immunogenic synthetic vaccines constructed by chemoselective ligation of repeat B-cell epitopes and a universal T-cell epitope of CS protein.

Nardin EH, Calvo-Calle JM, Oliveira GA, Clavijo P, Nussenzweig R, Simon R, Zeng W, Rose K.

Vaccine. 1998 Apr;16(6):590-600.

PMID:
9569470
17.
18.

The use of multiple antigen peptides in the analysis and induction of protective immune responses against infectious diseases.

Nardin EH, Oliveira GA, Calvo-Calle JM, Nussenzweig RS.

Adv Immunol. 1995;60:105-49. Review. No abstract available.

PMID:
8607369
19.

In vitro development of infectious liver stages of P. yoelii and P. berghei malaria in human cell lines.

Calvo-Calle JM, Moreno A, Eling WM, Nardin EH.

Exp Parasitol. 1994 Nov;79(3):362-73.

PMID:
7957756
21.

Immunogenicity of multiple antigen peptides containing B and non-repeat T cell epitopes of the circumsporozoite protein of Plasmodium falciparum.

Calvo-Calle JM, de Oliveira GA, Clavijo P, Maracic M, Tam JP, Lu YA, Nardin EH, Nussenzweig RS, Cochrane AH.

J Immunol. 1993 Feb 15;150(4):1403-12.

PMID:
7679427
22.
23.

Recognition of different domains of the Plasmodium falciparum CS protein by the sera of naturally infected individuals compared with those of sporozoite-immunized volunteers.

Calle JM, Nardin EH, Clavijo P, Boudin C, Stüber D, Takacs B, Nussenzweig RS, Cochrane AH.

J Immunol. 1992 Oct 15;149(8):2695-701.

PMID:
1401909
24.

Safety and immunogenicity of a recombinant sporozoite malaria vaccine against Plasmodium vivax.

Herrington DA, Nardin EH, Losonsky G, Bathurst IC, Barr PJ, Hollingdale MR, Edelman R, Levine MM.

Am J Trop Med Hyg. 1991 Dec;45(6):695-701.

PMID:
1763796
25.

Inhibitory activity against Plasmodium vivax sporozoites induced by plasma from Saimiri monkeys immunized with circumsporozoite recombinant proteins or irradiated sporozoites.

Millet P, Collins WE, Broderson JR, Bathurst I, Nardin EH, Nussenzweig RS.

Am J Trop Med Hyg. 1991 Jul;45(1):44-8.

PMID:
1907809
26.

Further studies on the immunization of Saimiri sciureus boliviensis with recombinant vaccines based on the circumsporozoite protein of Plasmodium vivax.

Collins WE, Nussenzweig RS, Ruebush TK 2nd, Bathurst IC, Nardin EH, Gibson HL, Campbell GH, Barr PJ, Broderson JR, Skinner JC, et al.

Am J Trop Med Hyg. 1990 Dec;43(6):576-83.

PMID:
1702586
27.

Widespread reactivity of human sera with a variant repeat of the circumsporozoite protein of Plasmodium vivax.

Cochrane AH, Nardin EH, de Arruda M, Maracic M, Clavijo P, Collins WE, Nussenzweig RS.

Am J Trop Med Hyg. 1990 Nov;43(5):446-51.

PMID:
2122747
28.
29.

Cellular and humoral immune responses to a recombinant P. falciparum CS protein in sporozoite-immunized rodents and human volunteers.

Nardin EH, Nussenzweig RS, Altszuler R, Herrington D, Levine M, Murphy J, Davis J, Bathurst I, Barr P, Romero P, et al.

Bull World Health Organ. 1990;68 Suppl:85-7.

30.

Conserved repetitive epitope recognized by CD4+ clones from a malaria-immunized volunteer.

Nardin EH, Herrington DA, Davis J, Levine M, Stuber D, Takacs B, Caspers P, Barr P, Altszuler R, Clavijo P, et al.

Science. 1989 Dec 22;246(4937):1603-6.

PMID:
2480642
31.

Sero-epidemiological studies of malaria in Indian tribes and monkeys of the Amazon Basin of Brazil.

de Arruda M, Nardin EH, Nussenzweig RS, Cochrane AH.

Am J Trop Med Hyg. 1989 Oct;41(4):379-85.

PMID:
2508499
32.

Immunization of Saimiri sciureus boliviensis with recombinant vaccines based on the circumsporozoite protein of Plasmodium vivax.

Collins WE, Nussenzweig RS, Ballou WR, Ruebush TK 2nd, Nardin EH, Chulay JD, Majarian WR, Young JF, Wasserman GF, Bathurst I, et al.

Am J Trop Med Hyg. 1989 May;40(5):455-64.

PMID:
2658634
33.

Genetic restriction of the murine humoral response to a recombinant Plasmodium vivax circumsporozoite protein.

Nardin EH, Barr PJ, Heimer E, Etlinger HM.

Eur J Immunol. 1988 Jul;18(7):1119-22.

PMID:
3136025
34.

Induction of sporozoite-specific memory cells in mice immunized with a recombinant Plasmodium vivax circumsporozoite protein.

Nardin EH, Barr PJ, Gibson HL, Collins WE, Nussenzweig RS, Nussenzweig V.

Eur J Immunol. 1987 Dec;17(12):1763-7.

PMID:
3319650
35.

Use of synthetic and recombinant peptides in the study of host-parasite interactions in the malarias.

Campbell GH, Aley SB, Ballou WR, Hall T, Hockmeyer WT, Hoffman SL, Hollingdale MR, Howard RJ, Lyon JA, Nardin EH, et al.

Am J Trop Med Hyg. 1987 Nov;37(3):428-44. No abstract available.

PMID:
2446515
36.

Inhibition of entry of Plasmodium falciparum and P. vivax sporozoites into cultured cells; an in vitro assay of protective antibodies.

Hollingdale MR, Nardin EH, Tharavanij S, Schwartz AL, Nussenzweig RS.

J Immunol. 1984 Feb;132(2):909-13.

PMID:
6317752
37.

Circumsporozoite proteins of malaria parasites contain a single immunodominant region with two or more identical epitopes.

Zavala F, Cochrane AH, Nardin EH, Nussenzweig RS, Nussenzweig V.

J Exp Med. 1983 Jun 1;157(6):1947-57.

38.

Structural similarities among the protective antigens of sporozoites from different species of malaria parasites.

Santoro F, Cochrane AH, Nussenzweig V, Nardin EH, Nussenzweig RS, Gwadz RW, Ferreira A.

J Biol Chem. 1983 Mar 10;258(5):3341-5. No abstract available.

39.

Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivax.

Nardin EH, Nussenzweig V, Nussenzweig RS, Collins WE, Harinasuta KT, Tapchaisri P, Chomcharn Y.

J Exp Med. 1982 Jul 1;156(1):20-30.

40.

Congenital transfer of antibodies against malarial sporozoites detected in Gambian infants.

Nardin EH, Nussenzweig RS, Bryan JH, McGregor IA.

Am J Trop Med Hyg. 1981 Nov;30(6):1159-63.

PMID:
7034558
41.

Antibodies to sporozoites: their frequent occurrence in individuals living in an area of hyperendemic malaria.

Nardin EH, Nussenzweig RS, McGregor IA, Bryan JH.

Science. 1979 Nov 2;206(4418):597-9.

PMID:
386511
42.

Stage-specific antigens on the surface membrane of sporozoites of malaria parasites.

Nardin EH, Nussenzweig RS.

Nature. 1978 Jul 6;274(5666):55-7. No abstract available.

PMID:
96355

Supplemental Content

Loading ...
Support Center